Advantis Corporation (ADVT) is focused on helping people take control of their health and pain management needs. By creating strategic partnerships with innovative companies in the nutraceutical and alternative health care industries, Advantis is uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Acquiring ownership in developing companies allows Advantis to provide consultation to improve product lines, expand distribution channels, and heighten brand value. With the healthcare and pain management sectors forecasting staggering growth, Advantis identifies and partners with those companies that possess the potential to capitalize on this trend.
Acquisitions and product developments ensure that Advantis reaches sustainable revenue growth in the near-term as it prepares for future market opportunities. CEO, Christopher Swartz envisions the success of Advantis Corporation through strengthened partnerships, innovative product development, and sustained focus on revenue-producing strategies. With the help of a diverse and skilled management team, Swartz has navigated Advantis towards enhancing its footprint in the evolving legal cannabis business, holistic pain management, and healthcare industries. Expertise in the legal aspects of the medical cannabis industry allows Advantis to work within the framework of the law to target opportunities along the supply-chain of this untapped, explosive growth industry.
Where We are as a Company:
1.Our goal has always been to create a great CBD product line. We have partnered withwww.Hemp2health.com out of Colorado as a source for the CBD oil. We have done our research and like their focus on chemical free growing and extracting. Lab tests show consistent quality and concentration and provide proof that it is free of chemicals. They have a patented cannabis strain that is very high in CBD.
2.We have also Licensed a Technology for preservation of Cannabis flowers. N2pack.com
3.We are also starting a finance division. Personal loans for Manufactures and retailers in the Cannabis space. We are partnering with a lead generation company https://leafhead.com/ . They have a very large following on their network of qualified professionals in this space.
ADVANTIS CORPORATION PRODUCTS AND HOLDINGS:
http://advantiscorp.com/wp-content/uploads/2016/10/Amster-Can-6154-240x300.jpg 240w, http://advantiscorp.com/wp-content/uploads/2016/10/Amster-Can-6154-768x960.jpg 768w, http://advantiscorp.com/wp-content/uploads/2016/10/Amster-Can-6154-819x1024.jpg 819w" style="height:1280px; width:1024px"> http://advantiscorp.com/wp-content/uploads/2016/12/advantis-corp-nug-smasher-300x225.jpg 300w, http://advantiscorp.com/wp-content/uploads/2016/12/advantis-corp-nug-smasher-768x576.jpg 768w" style="height:768px; width:1024px">
SEQUENCE THERAPY + FITNESS
Advantis Corp. recently acquired a 25% stake in Sequence Therapy, LLC. The company has an established client base of physicians and pain management specialists it works with to research and develop innovative techniques to treat the source of pain, rather than the symptoms. A laboratory gymnasium is maintained to study, educate, license and develop pain management techniques for patients and physicians to utilize. Sequence Therapy has developed an application over the past 10 years that it provides to health care professionals (under licensing agreement) that prescribe sequence therapy exercises for chronic pain.
Treatment of chronic pain is a $560 billion industry because physicians often use highly addictive opiates to treat the symptoms of pain, which usually exacerbates the problem. Sequence Therapy believes there is a better way. The company is developing non-addictive CBD (a cannabis extract) formulae that can be paired with sequenced therapy programs that can aid the execution of exercises targeting the source of chronic pain. Using the natural pain suppressant along with prescribed exercises will allow patients to safely reduce and in some cases rid themselves of chronic pain, without the damaging side effects of opiates.The company currently earns $500,000 in annual revenue from its existing client base; Advantis is executing a strategy to exponentially increase revenue through targeted marketing, branding, and distribution channels.
Oregon Advantis Cannabis, Washington Advantis Cannabis
Advantis Corp strives to be at the forefront of the coming “Green Rush”. Formed in 2015, Oregon Advantis Cannabis LLC and Washington Advantis Cannabis LLC are in the final stages of solidifying relationships with current producers and distributors of cannabis with the intent to acquire a majority share and controlling interest.
Natural Elements, Inc. is a non-profit, mutual benefit corporation that operates in accordance with California Health & Safety Sec. 11362(B)(1)(A) & 11362.7(H) Prop 215 S.B. 420. We are dedicated to providing a high quality and efficient, medical marijuana delivery service to all of our patients. Specializing in locally grown organic medicines, and edible products, we serve all qualified patients.
12-7-15 Advantis Corp. Announces Negotiations With Major Retail Chain
12-3-15 ADVANTIS CORP Financials
12-1-15 Ramoil Management Announces Name Change to Advantis Corp and a New Distribution agreement
11-9-15 Ramoil Management, Ltd. CEO Interview Details Future, Reveals New Company Name
11-2-15 Ramoil Management, Ltd. CEO Featured in Meet the CEO Interview
10-26-15 Ramoil Management, Ltd. Updates Website
10-19-15 Ramoil Management, Ltd. to File for Name Change
10-15-15 RAMOIL MANAGEMENT LTD Financials
10-13-15 Ramoil Management, Ltd. Takes Steps Toward Name Change
10-5-15 Ramoil Management, Ltd. Announces Negotiations With CleanVD(R)
9-28-15 Ramoil Management, Ltd. Reduces Debt
Share Structure Information
Pacific Stock Transfer
4045 South Spencer Street Suite 403 Las Vegas, NV 89119
Tel: (702) 361-3033 / (800) 785-PSTC Fax: (702) 433-1979
|ADVT Security Details || || |
|Share Structure || || |
|Market Value1 ||$3,611,789 ||a/o Nov 24, 2015 |
|Authorized Shares ||1,000,000,000 ||a/o Sep 30, 2014 |
|Outstanding Shares ||708,193,875 ||a/o Sep 30, 2014 |